Product image of Methylprednisolone Orion (Methylprednisolone) supplied by GNH India

Methylprednisolone Orion

Active Ingredient:
Methylprednisolone
Origin:
EU

Methylprednisolone Orion (Methylprednisolone)

Methylprednisolone, the active ingredient in Methylprednisolone Orion, is a glucocorticoid presented as an oral tablet for systemic use. It exerts anti‑inflammatory and immunosuppressive effects and is employed in the management of various inflammatory and autoimmune conditions in adults. The medication is indicated for conditions such as asthma exacerbations, rheumatoid arthritis, systemic lupus erythematosus, severe allergic reactions, and certain dermatologic disorders, providing clinicians with a versatile therapeutic option.

GNH India supplies Methylprednisolone Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylprednisolone is a systemic glucocorticoid used to control inflammation and immune‑mediated disease activity across several organ systems.

  • Acute exacerbations of asthma: reduces airway inflammation, improves airflow and relieves symptoms.
  • Rheumatoid arthritis and other inflammatory rheumatic diseases: decreases joint swelling, pain and structural damage.
  • Systemic lupus erythematosus: suppresses immune over‑activity and organ inflammation.
  • Severe allergic reactions: mitigates edema, hives and airway compromise.
  • Dermatologic inflammatory conditions: lessens skin redness, itching and lesion formation.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction up‑regulates anti‑inflammatory proteins while down‑regulating pro‑inflammatory cytokines, adhesion molecules, and enzymes such as phospholipase A2, resulting in broad immunosuppressive and anti‑edematous effects throughout the body.

Side Effects

Methylprednisolone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Increased appetite and weight gain.
  • Elevated blood glucose levels.
  • Mood changes, including irritability or euphoria.
  • Insomnia or sleep disturbances.

Serious or Rare Side Effects

  • Severe infections, including opportunistic pathogens.
  • Osteoporosis leading to fractures.
  • Adrenal suppression causing adrenal crisis.
  • Psychosis or severe mood disorders.

Precautions & Warnings

When prescribing methylprednisolone, clinicians should consider several precautionary measures to minimize risk.

  • Assess infection risk: screen for active or latent infections before initiation.
  • Monitor blood glucose: patients with diabetes may require dose adjustments.
  • Evaluate bone health: consider calcium/vitamin D supplementation and bone density monitoring.
  • Use lowest effective dose: limit duration to reduce systemic effects.
  • Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Avoid Interactions

Methylprednisolone can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase systemic exposure and risk of adverse effects.
  • Live vaccines: concurrent use can lead to uncontrolled infection.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal bleeding.
  • Anticoagulants (warfarin): may enhance anticoagulant effect, requiring INR monitoring.
  • Diabetes medications (insulin, oral hypoglycemics): may need dose adjustment due to hyperglycaemia.

Frequently Asked Questions

Methylprednisolone Orion is an oral glucocorticoid prescribed to reduce inflammation and suppress immune responses in conditions such as acute asthma exacerbations, rheumatoid arthritis, systemic lupus erythematosus, severe allergic reactions, and certain inflammatory skin disorders.

Methylprednisolone binds to intracellular glucocorticoid receptors, altering gene transcription. This up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, enzymes, and adhesion molecules, leading to reduced swelling, pain, and immune activity throughout the body.

The dose of Methylprednisolone Orion is individualized by the prescribing clinician based on the specific condition, severity, patient weight, response to therapy, and any concomitant medications. No standard dosing regimen is provided here.

Safety data for methylprednisolone in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylprednisolone is comparable in potency to prednisone but generally has a slightly higher anti‑inflammatory effect per milligram. Both belong to the glucocorticoid class, sharing similar mechanisms and side‑effect profiles, though dosing schedules may differ.

Store the oral tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Methylprednisolone Orion is taken by mouth, usually with a glass of water. It may be taken with or without food, but taking it with food can reduce gastrointestinal irritation. Follow the prescribing physician’s instructions for timing and duration.

Serious risks include severe infections, adrenal insufficiency, osteoporosis leading to fractures, and psychiatric effects such as psychosis or severe mood swings. Patients should be monitored regularly for signs of these complications.

Methylprednisolone should be avoided in individuals with uncontrolled systemic fungal infections, known hypersensitivity to the drug, or those receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, severe hypertension, or active peptic ulcer disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT